Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
Report ID | 165704 |
Drug Identification Number | 02139510 |
Brand name | SODIUM CHLORIDE INJECTION, USP |
Common or Proper name | SODIUM CHLORIDE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 234MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 200 mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-08-01 |
Estimated end date | 2022-08-21 |
Actual end date | 2022-08-15 |
Shortage status | Resolved |
Updated date | 2022-08-21 |
Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Sodium Chloride Injection, USP 4mEq/mL Maxivial® 200 mL effective August 1, 2022 until August 21, 2022. Once available, this product will remain on allocation. Contract customers will be allocated 100% of historical monthly demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-08-21 | French | Compare |
v4 | 2022-08-21 | English | Compare |
v3 | 2022-08-02 | English | Compare |
v2 | 2022-07-29 | French | Compare |
v1 | 2022-07-29 | English | Compare |
Showing 1 to 5 of 5